PAVmed (PAVM) Reports Q2, Provides Business Update

Go back to PAVmed (PAVM) Reports Q2, Provides Business Update

PAVmed Provides Business Update and Second Quarter Financial Results

August 15, 2023 8:17 PM EDT

EsoGuard® test volume continues to grow as Lucid makes strides with commercial expansion and additional supporting data

Veris Health prepares to launch the next generation of the Veris Cancer Care Platform along with strategic initiatives to develop a biopharma companion digital module to support new cancer therapeutics and to seek FDA clearance as a SaMD

Conference call and webcast to be held tomorrow, August 16th at 8:30 AM... More